Regulation of mprF in daptomycin-nonsusceptible Staphylococcus aureus strains

Area of Science:

• Microbiology
• Infectious Diseases
• Molecular Biology

Background:

• Staphylococcus aureus is a major cause of bloodstream infections.
• Daptomycin (DAP) is a critical antibiotic for treating serious S. aureus infections.
• Mechanisms of DAP nonsusceptibility, particularly involving the mprF gene, are crucial to understand.

Purpose of the Study:

• To investigate the regulation of mprF-mediated phosphatidylglycerol lysinylation in S. aureus.
• To determine the role of mprF mutations in in vitro DAP nonsusceptibility.
• To assess the impact of mprF mutations on endovascular virulence in vivo.

Main Methods:

• Utilized a well-characterized isogenic set of clinical bloodstream Staphylococcus aureus strains.
• Assessed the correlation between mprF gene expression and in vitro DAP susceptibility.
• Evaluated bacterial fitness in experimental infective endocarditis models.

Main Results:

• A positive correlation was observed between increased expression of a mutant mprF gene and reduced in vitro DAP susceptibility.
• No significant differences in bacterial fitness were detected between strains in experimental infective endocarditis.
• mprF gene expression is linked to DAP resistance mechanisms.

Conclusions:

• Mutant mprF gene expression is associated with decreased susceptibility to daptomycin in Staphylococcus aureus.
• mprF mutations do not appear to confer a fitness advantage or disadvantage in the context of endovascular infection.
• Further research into mprF regulation is warranted for understanding and combating DAP resistance.